Sol-Gel Technologies Ltd

NASDAQ:SLGL  
9.54
-0.10 (-1.04%)
Products

Sol-Gel Technologies Announces FDA Acceptance For Filing Of New Drug Application For Twyneo For The Treatment Of Acne Vulgaris

Published: 12/07/2020 12:32 GMT
Sol-Gel Technologies Ltd (SLGL) - Sol-gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo® for the Treatment of Acne Vulgaris.
Sol Gel Technologies Ltd - PDUFA Goal Date Set for August 1, 2021.